MedMen Enterprises Inc. (MMNFF) is facing a new lawsuit from the company’s former Chief Financial Officer James Parker. Parker filed his case on January 29 in the Superior Court of California in the County of Los Angeles claiming wrongful termination for an undetermined amount of damages.

MedMen spokesman Daniel Yi said that the company was unable to respond to the filing because it had not been officially served, but would do so once that happened.

Most cannabis companies are eager to list on Canadian exchanges, which has become the go-to location for the international marijuana companies seeking exposure to public markets.

However, some businesses prefer to operate on American exchanges, seeing a more mature market alongside larger pools of potential funding as a better opportunity to pursue. One Canadian cannabis producer, Flowr Corporation (TSXV: FLWR) announced today that it had completed an application to list on the NASDAQ.

Health Canada has suspended the sales license of an embattled Winnipeg-based cannabis producer after it was found to be non-compliant with the federal Cannabis Act.

The country’s federal health arm revoked the license on Monday following a review of recent activities with Bonify Medical Cannabis “to protect public health and public safety.”

In December, Bonify fired its three senior managers and suspended a board member after somehow obtaining 200 kilograms of unauthorized pot. Two of its strains — Cherry Lime Pie and Warlock Kush (both 3.5-gram varieties) — were found to be contaminated.

An internal investigation into Bonify also found that some of its employees were pressured to remain silent after voicing their concerns over the product.

Passage of the U.S. Farm Bill has ended a five-decade-long ban on industrial hemp (defined as cannabis with less than 0.3% THC), allowing nationwide legal hemp production in all 50 states. Importantly, this should allow companies to deduct business expenses against their taxes (IRS Section 280E), which should significantly increase the bottom line of most companies that carry hemp products.

The Farm Bill also lifts restrictions on banking, advertising, and marketing. Hemp/CBD companies will also be able to accept other forms of payment other than cash, including debit and credit cards. Today, we have identified three little-known hemp CBD stocks that have significant upside potential from the passage of the U.S. Farm Bill.

Go ahead and talk about marijuana and marijuana stocks -- it's no longer considered taboo. Following the passage of the Cannabis Act in Canada, and taking into account that two-thirds of all U.S. states have now legalized weed in some capacity, the legal pot industry has been validated as a legitimate business model. As a result, we've seen sales expectations and market caps go through the roof.

With the cannabis edibles market in Canada set to take off after the official retail legalization date, currently set for Oct. 17, 2019, we may soon be looking at our next $1-billion industry. According to the Canadian federal government, products such as cannabis-laced soda, chocolates, tea and other similar items should be cleared for sale by end of the year. And analysts are now suggesting that edibles—including beverages—will most likely be the hottest sellers in Canadian retail stores once they become available. However, one potential stumbling block is Canada’s current inventory shortage and delays in working out the regulations with the provinces, which may very well delay the sale of edibles. Bill Blair, Canada’s minister in charge of the legalization, warned on Jan.

The marijuana industry has come a mighty long way in a very short amount of time. If we look back to 2005, Gallup notes that just a third of all Americans it surveyed wanted to see cannabis legalized in the United States. By 2010, even with favorability toward weed improving, not a single state had given pot the green light at the recreational level. Now, in 2019, marijuana is legal medically in 33 U.S. states, 10 of which also allow adults to consume it, and 2 out of 3 Americans are in favor of its legalization.

We’ve witnessed how the cannabis industry has grown over the last couple years, and now that recreational legalization is in full effect, it’s time to begin looking towards the future.  In which direction is the cannabis industry headed?  Will we see mostly dried flower, or will cannabis edibles and concentrates dominate the marijuana market?  Many industry experts and investors believe that the next big thing will be cannabis edibles and derivative products.  Does this make sense?  Ontario Licensed Producer Indiva Ltd. seems to think so.

For the most part, marijuana stocks are known as up-and-coming opportunities.

And that’s because cannabis companies—even the well-known ones—are still relatively small compared to the blue-chip names in today’s market.

So it’s quite surprising to see Aurora Cannabis Inc (NYSE:ACB), a pot stock, mentioned in the same sentence as Apple Inc.(NASDAQ:AAPL), one of the biggest companies in the world by market capitalization.

 Aphria Inc.’s (APHA.TO 0.99%) recent winning streak that saw its stock surge almost 50 per cent in a four-day span was put at risk in early trading Tuesday.

The cannabis producer’s shares fell as much as 11.9 per cent at the start of trading before briefly breaking into positive territory. The company’s stock soared 47 per cent during a four-day winning streak that started last Wednesday.

While there was no particular news tied to the company’s recent climb, the sharp move higher signaled renewed investor confidence after the stock took a hit in December on the heels of a report from short sellers Quintessential Capital Management and Hindenburg Research. The report accused Aphria of buying a number of Latin American assets at highly inflated prices.